CareTrust REIT, Inc. (CTRE)
Free
No email, no account, no signup.
Pulling latest news for CareTrust REIT, Inc.…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NYSE
Type
Finance
Sector
Healthcare Real Estate Investment Trust
Market Cap
$8.8B
Market sentiment
Sentiment has clearly improved on raised guidance, the investment-grade rating, and strong investment momentum; recurring concerns remain around dilution and execution risk from rapid expansion (including the UK).
Why BUY ?
Raised guidance, very low leverage, and an investment-grade rating improve the risk-adjusted growth profile and lower the cost of capital, supporting a more constructive stance. The key offset is that a meaningful portion of growth is equity-funded (ATM), which can cap per-share upside if acquisitions/integration underdeliver.
- ADD in smaller tranches/on weakness; monitor equity dilution (ATM pace), integration of acquired portfolios, and progress in the UK-heavy pipeline.
We're already tracking CareTrust REIT, Inc. — here are the latest events we've registered
Recent News
- CareTrust REIT reported Q1 2026 with Normalized FFO/FAD of $0.48 per share (double-digit YoY growth), raised full-year guidance (FFO $2.00–$2.04; FAD $1.98–$2.02), increased the quarterly dividend to $0.39, and highlighted substantial post-quarter investments (~$864M) at ~8.9% blended stabilized yield. Moody’s upgraded the company to investment grade (Baa3), while ATM/equity issuance has been flagged as a potential dilution overhang.
Want to know how this news affects CareTrust REIT, Inc.? Order the analysis.
Order analysis – Catalysts
Moody’s upgrade to investment grade (Baa3)
Dilution Risk
Assessment: High
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of CareTrust REIT, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.